Agape ATP Corp

Agape ATP Corp(ATPC)股票分析

$2.380

+0.010 (+0.42%)收盤時

Loading chart…
High
2.430
Open
2.390
VWAP
2.38
Vol
28.54K
Mkt Cap
Low
2.340
Amount
68.02K
EV/EBITDA, TTM
0.00

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.

AI analysis of Agape ATP Corp (ATPC)

buy

Agape ATP Corp is a good buy right now due to its recent recovery in compliance with Nasdaq requirements and a significant increase in gross margin to 85.96%. The stock has shown a strong price increase of 130% following a new energy trading partnership, indicating positive market sentiment. However, the main risk is its year-to-date change of -54.67%, reflecting volatility and potential uncertainties ahead.

估值指標

The current forward P/E ratio for Agape ATP Corp (ATPC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
高估
0.00
低估
0.00

Alphio AI Price Scenarios for ATPC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ATPC

$1.53

情境價格

B

Base

Base · 50%ATPC

$1.40

情境價格

B

Bear

Bear · 25%ATPC

$1.25

情境價格

事件時間軸

2026-03-12 (ET)

09:20:00

Agape ATP Regains Nasdaq Listing Compliance

2026-03-10 (ET)

09:30:00

AGAPE ATP Enters Collaboration Agreement with Citadel Investment

2026-02-09 (ET)

20:00:00

Agape ATP Corp Trading Halted, News Pending

2026-02-06 (ET)

13:40:00

Agape ATP Files $200M Mixed Securities Shelf

2026-02-05 (ET)

09:10:00

Agape ATP Corporation Faces Potential Nasdaq Delisting

資訊

ATPC FAQ — answered by Alphio AI

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual. It operates in the Healthcare sector.

Agape ATP Corp is a good buy right now due to its recent recovery in compliance with Nasdaq requirements and a significant increase in gross margin to 85.96%. The stock has shown a strong price increase of 130% following a new energy trading partnership, indicating positive market sentiment. However, the main risk is its year-to-date change of -54.67%, reflecting volatility and potential uncertainties ahead.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始